NYSE · CDRE

Cadre Holdings, Inc.

$30.86 +$0.39 (+1.28%) 1D Market open

Key Metrics

$1.30B
Market cap
35.37×
P/E · TTM
$635.63M
Revenue · TTM
$36.87M
Net income
EPS · TTM $0.90
Dividend yield 1.2%
Free cash flow $60.61M
Beta · 1Y 1.35
EBITDA · TTM $73.05M
Gross margin 41.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 29
    From its Mar 2 high, the share price fell 41%.

    Peak close $46.07 on Mar 2; trough close $27.36 on Jun 29. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -41%
  • May 13
    The stock moved +10.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 13
  • Mar 11
    The stock moved -13.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 11

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.30B
Enterprise value$1.63B
Shares outstanding42.8M
52-wk range$25.73 – $48.76
Avg volume · 20D219.1K
Net cash −$324.56M
Book value / share$8.20
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies
ExchangeNYSE
About Cadre Holdings, Inc.
IPO dateNov 4, 2021
Employees2533

Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E35.37
P/S2.05
P/FCF21.52
EV/EBITDA22.29
EV/Sales2.56
Graham №$12.88

Profitability

Gross 41.5%
Operating 8.3%
Net 5.8%
FCF 9.5%
ROE / ROIC 11.4% · 5.6%

Financial Health

Current ratio2.26
Quick ratio1.33
Debt / equity1.09
Debt / EBITDA 5.01
Net cash −$324.56M
Working capital$177.60M

Cash Flow · TTM

Operating CF $68.84M
Capex −$8.23M
Free cash flow $60.61M
Buybacks
Dividends paid $15.87M
Shareholder yield 1.2%

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

2.7
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$12.88 vs $30.86
Trades 2.4× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings